iv glutathione for parkinson& 39 Parkinson's Disease Treatment Challenges in the clinical advancement
Description
PD affects roughly 0.3% of the general population, with prevalence rising to about 1% among individuals over 60 years of age ( The current therapeutic options for the management of PD aim to increase dopamine concentration at the synaptic level for symptomatic relief of motor deficits
Ngoi ra, nng ca n cng c th b suy gim dn theo tui tc
J Biol Sci
Shen et al
